The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications.

The present invention relates to a method of providing thermal and/or acoustic insulation to a structure, comprising the steps of: providing a substrate which comprises fibres; applying the substrate to the structure; blending the substrate with a binder composition before, during or after application of the substrate to the structure; allowing curing of the binder composition after the substrate and the binder composition have been applied to the structure; wherein the binder composition comprises at least one hydrocolloid. The present invention also relates to an insulated structure obtainable by said method.

Improved yields of melanin are obtained by incubating, in an optimized media with a disodium tyrosine substrate, a culture of Vibrio natriegens expressing a heterologous tyrosinase gene at a temperature of about 30 C.

The present invention discloses synthetic fusion gene comprising hex1 and pox1 genes, their process of preparation, polypeptide(s) encoded by the same and its use thereof for biological pre-treatment of biomass for the production of biodiesel.

A peptide nucleic acid derivative of Formula I is provided to tightly bind to a splice site within a pre-mRNA in a sequence specific manner. Given with excellent cell membrane permeability and strong affinity for RNA, the said peptide nucleic acid derivative induces exon skipping in cells treated with the peptide nucleic acid at sub-femtomolar concentration as naked oligonucleotide. The said compound shows therapeutic activity in subjects upon systemic administration even at 1 g/Kg or less, and therefore is useful to treat a disease or symptom at affordable treatment cost.

A method and a mineral wool product include a multiple of lamellae, such as a sandwich panel core. The product includes a plurality of lamellae cut from a mineral wool web, and bonded together by applying an adhesive on the surfaces of two adjacent lamellae to form a web-like product, wherein the adhesive comprises at least one hydrocolloid.

The invention relates to a mineral wool product comprising mineral fibres bound by a cured binder wherein the binder in its uncured state comprises at least one protein, and at least one enzyme.

The disclosure relates to compositions and methods for treatment of diseases associated with aberrant lysosomal function, such as fronto-temporal dementia (FTD). The disclosure also provides expression constructs comprising a transgene encoding progranulin or a portion thereof. The disclosure provides methods of treating FTD by administering such expression constructs to a subject in need thereof.

The present invention discloses synthetic fusion gene comprising hex1 and pox1 genes, their process of preparation, polypeptide(s) encoded by the same and its use thereof for biological pre-treatment of biomass for the production of biodiesel.

The invention relates to a formaldehyde-free binder composition for mineral fibres comprising at least one phenol and/or quinone containing compound, and at least one protein.